Effects of omeprazole consumption on serum levels of trace elements
ARTICLE IN PRESS
Contents lists available at
Journal of Trace Elements in Medicine and Biology
Effects of omeprazole consumption on serum levels of trace elements
Hamidreza Joshaghani , Taghi Amiriani , Gholamreza Vaghari , Sima Besharat , Aliasghar Molana ,
Mohammadtaghi Badeleh , Gholamreza Roshandel
a Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
b Biochemistry and Metabolic Disease Research Center, Golestan University of Medical Sciences„ Gorgan, Iran
c Golestan University of Medical Sciences, Gorgan, Iran
Project: Omeprazole is one of the most frequently prescribed drugs in patients with gastroesophageal
Received 21 December 2010
reflux disease (GERD). It increases the gastric pH and this in turn may change the intestinal absorption of
Accepted 7 February 2012
trace elements. This study was conducted to assess the effects of omeprazole consumption on the serum
level of trace elements.
Procedures: The studied subjects were selected from the list of patients referred to the gastroenterology
department of 5 Azar hospital in Golestan province of Iran for whom omeprazole was prescribed by a
gastroenterologist. Blood samples were obtained before (phase I) and after an eight-week period (phase
Gastroesophageal reflux disease
II) of omeprazole consumption. Serum levels of trace elements were assessed by the photometric method.
Results: Sixty seven patients were recruited of whom, 35.82% were males. There was no significant dif-
ference in serum levels of Fe, P, Ca and Cu between phases I and II. Serum concentration of Zn was
significantly lower in phase II than I (P = 0.02). The proportion of male patients with low Zn levels was
significantly higher in phase II (50%) than I (16.7%) (P = 0.01). We found no significant difference in the
proportion of female patients with low Zn levels between phase I (37.2%) and phase II (27.9%).
Conclusions: We found no significant reduction in serum levels of Fe, P, Ca and Cu in phase II. However, our
results showed that serum level of Zn was significantly lower after omeprazole consumption in males.
So, nutritional supplement of Zn should be considered in male patients treated with omeprazole.
2012 Elsevier GmbH. All rights reserved.
particles such as trace elements. Absorption of trace elements often
takes place in acidic media of stomach and proximal part of small
Gastroesophageal reflux disease (GERD) is a kind of disease
intestine. Some elements such as calcium (Ca), phosphorous (P)
occurred when distal esophageal muscle does not close the sphinc-
and iron (Fe) are soluble in acidic medium and insoluble in the
ter completely. This change results in abnormal reflux of gastric
alkaline environment gastric PH interferes with the
acid into the esophagus. The typical symptom of GERD is heart-
absorption of the above mentioned elements addition to indi-
burn It is estimated that GERD symptoms occur in up to
rect effect of omeprazole on the absorption of trace elements, some
40% of population is one of the most frequently
studies reported that omeprazole may directly block the absorption
prescribed drugs in GERD patients. However, sometimes patients
of Ca and other minerals
take it inappropriately and without physician's prescription
Trace elements play important roles in a number of body func-
Omeprazole is available in the form of 20 mg capsule can
tions. Ca is the most abundant mineral in the body and a large
relieve sign and symptoms of GERD. This drug is considered as an
amount of it is deposited in bone and teeth. Reduction of Ca level in
anti-gastric acid agent and its mechanism is to inhibit proton pump
the body may cause some abnormalities such as osteoporosis and
in the gastric mucosa and consequently, to reduce gastric acidity.
osteomalacia and rickets. The absorption of intestinal P follows the
Omeprazole inhibits proton pumps by blocking the production of
absorption of Ca. So, impairing the absorption of Ca due to omepra-
gastric hydrochloric acid and changes the gastric pH to alkaline
zole consumption may in turn lead to changes in the absorption of
range. Gastric acidity plays an important role in absorption of food
P (Zn) deficiency may results in growth delay, infertility
in males, immune system dysfunction and cognitive impairment
(Cu) is a co-factor for at least 30 enzymes. It is directly
absorbed through gastrointestinal (GI) tract Over-use
Corresponding author at: Number 77, Qabooseieh Passage, Valiasr Street, Gorgan
of omeprazole may cause trace elements deficiency and this may
49166-53588, Iran. Tel.: +98 171 2340835; fax: +98 171 2369210.
E-mail address: (G. Roshandel).
lead to abnormalities in some of important body functions.
0946-672X/$ – see front matter 2012 Elsevier GmbH. All rights reserved.
Please cite this article in press as: Joshaghani H, et al. Effects of omeprazole consumption on serum levels of trace elements. J Trace
Elem Med Biol (2012),
ARTICLE IN PRESS
H. Joshaghani et al. / Journal of Trace Elements in Medicine and Biology xxx (2012) xxx–xxx
Golestan province, located in northeast of Iran, is known as
a high-risk area for upper GI (UGI) cancers. Symptoms of UGI
problems, including GERD may wrongly be considered as mani-
festations of a malignant condition. These patients are frequently
visited by various physicians. This in turn may result in inappro-
priate use and over-use of medicines such as omeprazole in this
region. Therefore, we conducted this study to determine the effects
of omeprazole consumption on the serum levels of Cu, Zn, Ca,
P, Fe and erythrocyte indices of patients in Golestan province of
Materials and methods
The studied subjects were selected from the list of patients
referred to the department of gastroenterology in 5 Azar hospital
of Golestan province of Iran for whom omeprazole was prescribed
by a gastroenterologist. Patients who did not take the drug regu-
larly or consumed supplementary drugs containing Ca, P, Fe, Cu
and Zn were excluded. Patients were referred to the biochemi-
cal laboratory of the Golestan University of Medical Sciences for
blood sampling in two phases. The first sampling (phase I) was
done before starting omeprazole therapy and the second sam-
ple (phase II) was collected after finishing an eight-week period
of omeprazole consumption. Three ml of blood was taken from
each of the participants. Complete Blood Count (CBC) was per-
formed immediately after sampling by cell counter Sysmex KX-21,
Japan. Then, serum was separated and stored at −80 ◦C until used.
The trace elements were measured by Mindray BS-200 autoana-
lyzer, China. Ca, P and Fe were assayed by Parsazmoon kit (Iran).
Cu and Zn were assessed by Greiner kit (Germany) and Elithec
kit (France), respectively. To reduce the bias of the colorimetric
and chemical methods, all tests were performed twice, and the
mean values were considered for analysis. Paired t-test, Student's
t-test, Mann–Whitney U test and Chi-square test were used for
data analysis. P-values of less than 0.05 were considered as sig-
Sixty seven 20–50 years-old patients were recruited in the
study. Twenty four (35.82%) of the participants were male. Serum
concentration of Zn was significantly lower in phase II than phase
I (P = 0.02). There was no significant difference in serum levels of
Fe, P, Ca and Cu between phases I and II. the mean
and standard deviation of trace elements before and after omepra-
zole consumption. The results of erythrocyte indices are shown in
Serum levels of Ca and P in all male patients were within ref-
erence interval before omeprazole consumption. After omeprazole
consumption, the levels of Ca and P in 16.7% of male patients were
lower than reference interval. The proportion of male patients with
low Cu levels was the same in phases I and II. The proportion of
male patients with low Zn levels was significantly higher in phase
II (50%) than phase I (16.7%) (P = 0.01). After omeprazole consump-
tion, serum concentration of all variables except Fe and Cu were
lower than reference interval in 16.7% of males.
Serum levels of Fe, Cu and Ca were within reference interval in
all females both in phases I and II. All female patients had normal
levels of P before omeprazole consumption, but serum level of P in
9.3% of females was lower than reference interval in phase II. We
found no significant difference in the proportion of female patients
with low Zn levels between phase I (37.2%) and phase II (27.9%)
Please cite this article in press as: Joshaghani H, et al. Effects of omeprazole consumption on serum levels of trace elements. J Trace
Elem Med Biol (2012), doi:
ARTICLE IN PRESS
H. Joshaghani et al. / Journal of Trace Elements in Medicine and Biology xxx (2012) xxx–xxx
Discussion and conclusion
The aim of this study was to assess the effects of omeprazole
consumption on serum levels of trace elements. There was a sig-
nificant difference in serum levels of Zn and Cu between males
and females before omeprazole consumption. This may be due to
differences in nutritional status or physiological state of the dis-
ease between males and females. We found that Zn had more
been affected by omeprazole consumption than other variables.
Our findings showed a significant reduction in serum Zn levels
after omeprazole consumption in males. In the other hand, the
proportion of male patients with low Zn level was 16.7% and 50%
before and after omeprazole consumption, respectively. Hiroshi
et al. reported a significant lower serum Zn level in omeprazole
treated rats than controls result of a study by Ozutemiz
et al. was in line with ours and suggested that omeprazole reduces
intestinal Zn absorption by decreasing gastric pH results of
Alastair's study suggested that low gastric pH may not be necessary
for intestinal absorption of Zn
Our results showed no significant difference in serum levels
of Ca, Fe, Cu and P between phases I and II. Mizunashi et al.
reported that elimination of Ca through urine decreased after
using omeprazole the study of Graziani et al., serum level
of Ca was decreased significantly after omeprazole consumption.
They reported no significant difference in the placebo group. They
also found no significant relationship between serum P level and
omeprazole or placebo consumption Edemilson Cardoso da
Conceic et al. reported a significant increase in serum transferrin
and a decrease in hepatic Iron after four weeks as well as a reduction
in Hb level after six weeks of omeprazole consumption in rats. Cases
received Iron supplement (Fe or Fe3+) in addition with omepra-
zole showed no difference in Hb and serum transferrin compare to
Serfaty-Lacrosniere et al. suggested that omeprazole consump-
tion led to a significant increase in gastric pH in omeprazole treated
patients than controls. However, they did not find a significant dif-
ference in intestinal absorption of Ca, P, Mg and Zn between the two
groups. So, they concluded that change in gastric pH may not be
the only factor affecting the intestinal absorption of trace elements
of the results of our study considering Ca and P were in
line with Serfaty-Lacrosniere's one. Although, chemical method is
not the gold standard for assessing these trace elements, but it is
routinely used in medical laboratories and physicians accept the
results of this method for clinical judgment. Therefore, the results
of the present research are near to the results reported in medi-
cal laboratories. Serum level of trace elements was assessed by the
same method both in phases I and II. So, method variation was not
an important concern for interpretation of the results in this study.
In conclusion, we found no significant reduction in serum levels
of Fe, P, Ca and Cu in phase II compare to phase I. However, our
results showed that serum level of Zn was significantly lower after
omeprazole consumption in males. So, nutritional supplements of
Zn should be considered in male patients treated by omeprazole.
This project was approved and supported by Golestan University
of Medical Sciences.
[1] Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE. Cisapride treatment
for gastro-oesophageal reflux in children. Cochrane Database of Systematic
[2] Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Gastroenterol-
ogy Clinic of North America 2010;39:39–46.
Please cite this article in press as: Joshaghani H, et al. Effects of omeprazole consumption on serum levels of trace elements. J Trace
Elem Med Biol (2012),
ARTICLE IN PRESS
H. Joshaghani et al. / Journal of Trace Elements in Medicine and Biology xxx (2012) xxx–xxx
[3] Thakor AS, Burke A, Handfield-Jones S, Sinha A, Palmer M, Burns A, et al. Toxic
[10] Ozutemiz AO, Aydin HH, Isler M, Celik HA, Batur Y. Effect of omeprazole on
epidermal necrolysis and neutropaenia: complications of omeprazole. Derma-
plasma zinc levels after oral zinc administration. Indian Journal of Gastroen-
[4] Hasan A, Abul Kalam Azad M, Ullah MA, Mahbub Latif AH, Hasnat A. Relative
[11] Turnbull AJ, Wood RJ, Russell RM. Hypochlorhydria does not inhibit zinc absorp-
bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated
tion in the rat. Nutrition Research 1992;12:999–1008.
tablet in healthy Bangladeshi volunteers. International Journal of Clinical Phar-
[12] Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of
macology and Therapeutics 2009;47:215–21.
H+,K(+)-ATPase, on bone resorption in humans. Calcified Tissue International
[5] O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton
pump inhibitors on calcium carbonate absorption in women: a randomized
[13] Graziani G, Como G, Badalamenti S, Finazzi S, Malesci A, Gallieni M, et al.
crossover trial. American Journal of Medicine 2005;118:778–81.
Effect of gastric acid secretion on intestinal phosphate and calcium absorp-
[6] Dujsikova H, Dite P, Tomandl J, Sevcikova A, Precechtelova M. Occurrence
tion in normal subjects. Nephrology, Dialysis, Transplantation 1995;10:
of metabolic osteopathy in patients with chronic pancreatitis. Pancreatology
[14] Edemilson Cardoso da Conceic E, Shuhama T, Izumi C, de Freitas O. Iron
[7] Prasad AS. Impact of the discovery of human zinc deficiency on health. Journal
supplementation prevents the development of iron deficiency in rats with
of American College Nutrition 2009;28:257–65.
omeprazole-induced hypochlorhydria. Nutrition Research 2001;21:1201–8.
[8] Zatta P, Frank A. Copper deficiency and neurological disorders in man and
[15] Serfaty-Lacrosniere C, Wood RJ, Voytko D, Saltzman JR, Pedrosa M, Sepe TE,
animals. Brain Research Review 2007;54:19–33.
et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit
[9] Hiroshi Hara, Ayako Konishi, Takanori Kasai. Contribution of the cecum and
intestinal absorption of calcium, phosphorous, magnesium or zinc from food
colon to zinc absorption in rats. Journal of Nutrition 2000;130:83–9.
in humans. Journal of American College Nutrition 1995;14:364–8.
Please cite this article in press as: Joshaghani H, et al. Effects of omeprazole consumption on serum levels of trace elements. J Trace
Elem Med Biol (2012), doi:
Source: http://www.joshaghani.ir/uploads/Omeprazol-JTEMB.pdf
2013 MD South Australia Research Reports Once again, it is my great pleasure to be able to write these Research Reports for you. In this instance they will mainly be taken up with news from clinical/scientific research conferences that I have attended since writing my previous annual report, backed up in part by information from medical/scientific journal articles that I have read in the meantime.
Proceeding of 6th ICGRC 2015 6-Gingerol from Zingiberaceae as a Result of Reverse Docking for Prostate's Cancer Potential Drug Candidate Haqqi Anajili Setyanto1, Arindra Trisna Widiansyah1, Zainul Mustofa1 1 Postgraduate of Educational Biology, State University of Malang, Malang, Indonesia Prostate cancer is a cancer that attacks the prostate gland causing the death rate which is high enough. One of the causes ofprostate cancer is the androgen receptor (AR) in the gland cells that initiates the formation of excess cell proliferation, thuscausing prostate cancer. AR inhibitor that is known is antiandrogen (biculatamide and enzalutamide). This study aimed to test the6-gingerol compound of ginger as an AR inhibitor drug candidate for prostate cancer using silico methode. The 3D structure ofthe 6-gingerol compound was taken from PubChem, the prediction of targeted protein used SwissTargetPrediction andPharmapper, analysis and docking 6-gingerol and antiandrogens with AR using Pyrx software, visualization compounds andprotein interactions using PyMOLsoftware. Visualization results shows that the interaction of 6-gingerol, biculatamide, andenzalutamide with AR have the same site. This proves that the 6-gingerol is potential as anAR inhibitor candidate.